Alyeska Investment Group
ASXC

Alyeska Investment Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Alyeska Investment Group’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-26,923
Closed -$1.05M – 545
2015
Q2 		$1.05M Buy
+26,923
New +$1.24M 0.01% 406

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Alyeska Investment Group's ASXC Position: Q3 2015 in Review

Alyeska Investment Group sold out of Asensus Surgical, Inc. (ASXC) in Q3 2015, closing a stake of 26,923 shares — an estimated $1.05M sold.

Alyeska Investment Group first reported a position in ASXC in Q2 2015 and held it in 1 quarter. The position peaked at $1.05M in Q2 2015. 67 funds tracked by Wall St. Rank hold ASXC as of Q3 2015.

  • Alyeska Investment Group reported no remaining Asensus Surgical, Inc. position as of Q3 2015 after selling out during the quarter.
  • Alyeska Investment Group sold 26,923 Asensus Surgical, Inc. shares in Q3 2015, an estimated $1.05M.
  • Alyeska Investment Group first reported a position in Asensus Surgical, Inc. in Q2 2015 and held it in 1 quarter.
  • Alyeska Investment Group's Asensus Surgical, Inc. position peaked at $1.05M in Q2 2015.
  • 67 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2015.

Based on Alyeska Investment Group's 13F filing for Q3 2015, filed 16 Nov 2015.